IL2 and osteosarcoma: These finding were not dose dependent and were consistent with previous preclinical studies that showed an increase in systemic NK cell activation after administration of oral Salmonella-IL2, which may account for the effect of this therapy in decreasing the rate of metastatic osteosarcoma to the lung in the dog (an organ not typically associated with S. typhimurium infiltration).